Published in J Bacteriol on May 10, 2013
Structure of the hemoglobin-IsdH complex reveals the molecular basis of iron capture by Staphylococcus aureus. J Biol Chem (2014) 0.90
Heme uptake in bacterial pathogens. Curr Opin Chem Biol (2014) 0.89
Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis (1992) 10.85
Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis (1991) 7.05
Bacterial iron sources: from siderophores to hemophores. Annu Rev Microbiol (2004) 5.55
Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS (1988) 4.85
Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob Agents Chemother (1978) 3.23
TonB-dependent transporters: regulation, structure, and function. Annu Rev Microbiol (2010) 2.72
Chancroid and Haemophilus ducreyi: an update. Clin Microbiol Rev (1995) 2.30
Standardization of the experimental model of Haemophilus ducreyi infection in human subjects. J Infect Dis (1998) 2.12
Structural biology of bacterial iron uptake. Biochim Biophys Acta (2007) 1.90
The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria. Sex Transm Dis (1997) 1.86
An isogenic hemoglobin receptor-deficient mutant of Haemophilus ducreyi is attenuated in the human model of experimental infection. J Infect Dis (2000) 1.69
A hemoglobin-binding outer membrane protein is involved in virulence expression by Haemophilus ducreyi in an animal model. Infect Immun (1996) 1.60
Characterization of the hgbA locus encoding a hemoglobin receptor from Haemophilus ducreyi. Infect Immun (1995) 1.56
Use of heme-protein complexes by the Yersinia enterocolitica HemR receptor: histidine residues are essential for receptor function. J Bacteriol (1999) 1.54
Target cell range of Haemophilus ducreyi hemolysin and its involvement in invasion of human epithelial cells. Infect Immun (1999) 1.35
Iron sources for Haemophilus ducreyi. J Med Microbiol (1991) 1.33
Haemophilus ducreyi Outer membrane determinants, including DsrA, define two clonal populations. Infect Immun (2005) 1.23
Characterization of the outer membrane receptor ShuA from the heme uptake system of Shigella dysenteriae. Substrate specificity and identification of the heme protein ligands. J Biol Chem (2007) 1.20
Prevalence of, antibody response to, and immunity induced by Haemophilus ducreyi hemolysin. Infect Immun (1999) 1.13
Identification of amino acid residues involved in heme binding and hemoprotein utilization in the Porphyromonas gingivalis heme receptor HmuR. Infect Immun (2006) 1.06
Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid. Infect Immun (2006) 1.03
Evaluation of the repertoire of the TonB-dependent receptors of Haemophilus ducreyi for their role in virulence in humans. J Infect Dis (2008) 0.94
Identification of functionally important regions of a haemoglobin receptor from Neisseria meningitidis. Microbiology (2003) 0.93
Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA with adjuvant monophosphoryl lipid A protects swine from a homologous but not a heterologous challenge. Infect Immun (2010) 0.89
An immunogenic, surface-exposed domain of Haemophilus ducreyi outer membrane protein HgbA is involved in hemoglobin binding. Infect Immun (2009) 0.87
Passive immunization with a polyclonal antiserum to the hemoglobin receptor of Haemophilus ducreyi confers protection against a homologous challenge in the experimental swine model of chancroid. Infect Immun (2011) 0.77
Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity. J Immunol (2000) 2.06
Crystallographic refinement of ricin to 2.5 A. Proteins (1991) 1.96
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes (2000) 1.92
Positive and negative symptoms in families with schizophrenia. Schizophr Res (1993) 1.74
Structure of ricin A-chain at 2.5 A. Proteins (1991) 1.57
Clozapine: current status and role in the pharmacotherapy of schizophrenia. Can J Psychiatry (1996) 1.38
A general technique for computing evolutionarily stable strategies based on errors in decision-making. J Theor Biol (1997) 1.29
Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry. J Exp Med (1999) 1.19
Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells. J Immunol (2000) 1.17
Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class I tetramers. J Immunol (2001) 1.15
The 2.5 A structure of pokeweed antiviral protein. J Mol Biol (1993) 1.13
Poor binding of a HER-2/neu epitope (GP2) to HLA-A2.1 is due to a lack of interactions with the center of the peptide. J Biol Chem (1999) 1.12
Class I major histocompatibility complex anchor substitutions alter the conformation of T cell receptor contacts. J Biol Chem (2001) 1.08
T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery. J Immunol (2000) 1.05
Giant-cell centrioles. Science (1967) 1.04
Correlated switch binding and signaling in bacterial chemotaxis. J Biol Chem (2000) 0.99
Accessibility control of V(D)J recombination: lessons from gene targeting. Adv Immunol (1998) 0.96
Cloning, overexpression, purification, and immunobiology of an 85-kilodalton outer membrane protein from Haemophilus ducreyi. Infect Immun (2001) 0.95
Should females prefer to mate with low-quality males? J Theor Biol (2008) 0.91
Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine. J Clin Psychopharmacol (2001) 0.89
Allelic diversity at the DLA-88 locus in Golden Retriever and Boxer breeds is limited. Tissue Antigens (2012) 0.88
Assessment of delayed-type hypersensitivity in man: a comparison of the "Multitest" and conventional intradermal injection of six antigens. Clin Immunol Immunopathol (1985) 0.87
CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia. J Clin Psychopharmacol (2001) 0.85
T cell activity correlates with oligomeric peptide-major histocompatibility complex binding on T cell surface. J Biol Chem (2001) 0.84
Polyarthritis following intravesical BCG immunotherapy. Report of a case and review of 26 cases in the literature. Rev Rhum Engl Ed (1999) 0.84
Peptide binding by class I and class II MHC molecules. Biopolymers (1997) 0.82
CD8(+) T cells express a T-helper 1--like phenotype after burn injury. Surgery (2001) 0.82
The structural basis for the increased immunogenicity of two HIV-reverse transcriptase peptide variant/class I major histocompatibility complexes. J Biol Chem (1999) 0.82
Hutchinson-Gilford progeria syndrome: oral and craniofacial phenotypes. Oral Dis (2009) 0.81
Gorillas with spondyloarthropathies express an MHC class I molecule with only limited sequence similarity to HLA-B27 that binds peptides with arginine at P2. J Immunol (2001) 0.81
A 43 kDa DNA binding protein from the pea chloroplast interacts with and stimulates the cognate DNA polymerase. Nucleic Acids Res (1996) 0.81
A tricyclic ring system replaces the variable regions of peptides presented by three alleles of human MHC class I molecules. Chem Biol (1995) 0.81
Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule. J Immunol (1997) 0.79
Calcium incorporation in the developing cartilaginous epiphysis. Calcif Tissue Res (1968) 0.79
Cell-mediated immunity to hepatitis B virus antigens in mice: correlation of in vivo and in vitro assays. Clin Exp Immunol (1986) 0.79
Covalent HLA-B27/peptide complex induced by specific recognition of an aziridine mimic of arginine. Proc Natl Acad Sci U S A (1996) 0.78
Class I MHC is stabilized against thermal denaturation by physiological concentrations of NaCl. Biochemistry (2000) 0.78
Intracellular calcium in epithelial, cartilage and bone cells. Calcif Tissue Res (1970) 0.76
Dexamethasone inhibits apoptosis of eosinophils isolated from hypereosinophilic patients. Immunobiology (2001) 0.76
Clinical use of clozapine in a major urban setting: one year experience. J Psychiatry Neurosci (1995) 0.75
A human myeloma IgA with a hybrid heavy chain resulting from putative somatic gene conversion. Eur J Immunol (1993) 0.75
Recent advances in the structure-activity relationships of substituted corticosteroids. J Steroid Biochem (1975) 0.75
[Thrombopenia following treatment with omeprazole]. Presse Med (1993) 0.75
Granular myoblastoma: perineal neoplasm of probable neural origin. Urology (1977) 0.75
[Non-bacterial thrombosing endocarditis. Apropos of 2 cases]. Ann Cardiol Angeiol (Paris) (1997) 0.75
[Exposure to blood accidents in a university hospital. Results of 1-year surveillance]. Presse Med (2000) 0.75
Biologic activity of 16 -methyldichlorisone-17-butyrate in the rat and dog. Steroids (1973) 0.75
[Filling the thymic space after treatment of Hodgkin's disease: rebound or relapse]. Rev Pneumol Clin (2007) 0.75
Myocarditis associated with hepatic encephalopathy. J Indian Med Assoc (1983) 0.75
[Autoimmune hepatitis and lupus syndrome associated with minocycline]. Rev Med Interne (1999) 0.75
Metabolism of radioactive calcium by cartilage. Clin Orthop Relat Res (1968) 0.75
Enhancing cytotoxic T cell responses with altered-peptide ligands. Arch Immunol Ther Exp (Warsz) (2001) 0.75
Biologic action of betamethasone 17,21-dipropionate in rat and dog. Steroids (1972) 0.75